Risk of community‐acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population‐based case–control study

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pds.1715PMID 19235776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proton pump inhibitor use and the risk of community-acquired pneumonia.

  2010cited by this paper
• British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009

  2009cited by this paper
• The incidence of pneumonia using data from a computerized general practice database

  2008cited by this paper
• Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia

  2008cited by this paper
• Statins for infection and sepsis: a systematic review of the clinical evidence.

  2008cited by this paper
• Use of ACE inhibitors and risk of community-acquired pneumonia: a review

  2008cited by this paper
• Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

  2007influential reference
• Statins and the Risk of Pneumonia: A Population‐Based, Nested Case‐Control Study

  2007cited by this paper
• Statin treatment and reduced risk of pneumonia in patients with diabetes

  2006influential reference
• Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs

  2006influential reference
• Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study

  2006cited by this paper
• Therapy With Gastric Acidity Inhibitors Increases the Risk of Acute Gastroenteritis and Community-Acquired Pneumonia in Children

  2006cited by this paper
• The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia

  2005cited by this paper
• Comparison of the properties of the five soluble guanylyl cyclase subunits in Drosophila melanogaster

  2005cited by this paper
• How accurate are Townsend Deprivation Scores as predictors of self-reported health? A comparison with individual level data.

  2005cited by this paper
• Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.

  2005cited by this paper
• Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

  2004cited by this paper
• Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.

  2004cited by this paper
• Feasibility study and methodology to create a quality-evaluated database of primary care data.

  2004cited by this paper
• Gastric acid‐suppressive therapy and community‐acquired respiratory infections

  2003cited by this paper
• Community-based estimates of incidence and risk factors for childhood pneumonia in Western Sydney

  2003cited by this paper
• BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

  2001cited by this paper
• Do smoking parents seek the best advice for their asthmatic children?

  2001cited by this paper
• Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community

  2001cited by this paper
• Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community.

  2000cited by this paper
• Use of comorbidity scores for control of confounding in studies using administrative databases.

  2000cited by this paper
• Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients.

  1999cited by this paper
• Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.

  1993cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• Which deprivation? A comparison of selected deprivation indexes.

  1991cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Prospective study of the aetiology and outcome of pneumonia in the community.

  1987cited by this paper

• Impact of Long-Term Statin Therapy on Incidence and Severity of Community-Acquired Pneumonia: A Real-World Data Analysis

  2025cites this paper
• Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study

  2024cites this paper
• Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis

  2021cites this paper
• Host-informed therapies for the treatment of pneumococcal pneumonia.

  2021cites this paper
• Clinical characteristics and outcomes of community-acquired pneumonia in western Saudi Arabia: A four-year retrospective analysis of medical records.

  2021cites this paper
• Proton-Pump Inhibitor Use and Risk of Community-Acquired Pneumonia in Congenital Heart Disease Patients

  2021cites this paper
• Guia de prática clínica: sinais e sintomas do trato gastrointestinal: azia (acidez/pirose) e dispepsia

  2020cites this paper
• Renin-Angiotensin-Aldosterone-System Blocking Drugs in Patients with SARS-CoV-2 - Systematic Review and Meta-Analysis

  2020cites this paper
• Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy

  2020cites this paper
• Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade: Systematic review and meta‐analysis

  2020cites this paper
• Risk of viral infection in patients using either angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: A nationwide population-based propensity score matching study.

  2020cites this paper
• Association of Increased Risk of Pneumonia and Using Proton Pump Inhibitors in Patients With Type II Diabetes Mellitus

  2019cites this paper
• Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients

  2019cites this paper
• Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta‐analysis of randomized controlled trials and observational studies

  2019cites this paper
• Drugs that increase the risk of community-acquired pneumonia: a narrative review

  2018cites this paper
• Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study

  2018cites this paper
• The double-sidedness of cough in the elderly.

  2018cites this paper
• Current and emerging evidence for immunomodulatory therapy in community-acquired pneumonia

  2017cites this paper
• Prophylactic Acid‐Suppressive Therapy in Hospitalized Adults: Indications, Benefits, and Infectious Complications

  2017cites this paper
• The Use of Statins and Risk of Community-Acquired Pneumonia

  2017cites this paper
• Factors associated with early treatment failure in adult hospitalized patients with community-acquired pneumonia

  2017cites this paper
• Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

  2016cites this paper
• Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study

  2016cites this paper
• Open Peer Review

  2016cites this paper
• An investigation of multimorbidity measures as risk factors for pneumonia in elderly frail patients admitted to hospital.

  2016cites this paper
• The best of respiratory infections from the 2015 European Respiratory Society International Congress

  2016cites this paper
• [Management of Adult Community-acquired Pneumonia and Prevention - Update 2016].

  2016cites this paper
• Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention – Update 2016

  2016cites this paper
• Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study

  2015cites this paper
• Recurrent Pneumonia: A Review with Focus on Clinical Epidemiology and Modifiable Risk Factors in Elderly Patients

  2015cites this paper
• Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults

  2015cites this paper
• Community-Acquired Pneumonia in Elderly Patients With Diabetes Mellitus: Outcomes and Time to First Dose of Appropriate Antibiotic Therapy

  2015cites this paper
• Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis

  2015cites this paper
• Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: a comprehensive review.

  2015cites this paper
• Pharmacogenomic testing: the case for CYP2C19 proton pump inhibitor gene-drug pairs.

  2014cites this paper
• Sources of heterogeneity in case–control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia

  2014cites this paper
• Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis

  2014cites this paper
• Acid suppressive agents and risk of Mycobacterium Tuberculosis: case–control study

  2014cites this paper
• The Effect of Statin Therapy on the Incidence of Infections: A Retrospective Cohort Analysis

  2014cites this paper
• A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.

  2014cites this paper
• Study of the Association Between Hip Fracture and Acid‐Suppressive Drug Use in a UK Primary Care Setting

  2014cites this paper
• The effects of statin use on the development of tuberculosis among patients with diabetes mellitus.

  2014cites this paper
• Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children.

  2013cites this paper
• Administration of Proton Pump Inhibitors and Risk of Systemic Side Effects

  2013cites this paper
• The Role of Statins in Prevention and Treatment of Community Acquired Pneumonia: A Systematic Review and Meta-Analysis

  2013cites this paper
• review pneumonia in adults in Europe : a literature Risk factors for community-acquired

  2013cites this paper
• Emerging roles for cholesterol and lipoproteins in lung disease.

  2013cites this paper
• Modifiable Risk Factors for Pneumonia Requiring Hospitalization of Community‐Dwelling Older Adults: The Health, Aging, and Body Composition Study

  2013cites this paper
• Risk Factors for Falls with Use of Acid-Suppressive Drugs

  2013cites this paper
• Oropharyngeal flora in patients admitted to the medical intensive care unit: clinical factors and acid suppressive therapy.

  2013cites this paper
• Association between statins and infections after coronary artery bypass grafting.

  2013cites this paper
• Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

  2013cites this paper
• Risk factors for community-acquired pneumonia in adults in Europe: a literature review

  2013cites this paper
• The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review.

  2013cites this paper
• Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease?

  2013cites this paper
• Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

  2013cites this paper
• [Emergent adverse effects of proton pump inhibitors].

  2013cites this paper
• Effets indésirables émergents des inhibiteurs de la pompe à protons

  2013cites this paper
• Inhibitori protonske pumpe – primena i bezbednost

  2013cites this paper
• Angiotensin‐converting enzyme inhibitor use and pneumonia risk in community‐dwelling older adults: results from a population‐based case–control study

  2012cites this paper
• Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis

  2012influential citation
• The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial

  2012cites this paper
• Targeting Outpatient Drug Safety

  2012cites this paper
• The risks of PPI therapy

  2012cites this paper
• Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients

  2012cites this paper
• Quality improvement in action Glad you brought it up: a patient-centred programme to reduce proton-pump inhibitor prescribing in general medical practice

  2012cites this paper
• Frecuencia de la prescripción de los inhibidores de bomba de protones basada en guías de práctica clínica en pacientes hospitalizados en dos hospitales docentes de Lima - Perú

  2012cites this paper
• Are proton pump inhibitors associated with the development of community- acquired pneumonia?

  2012cites this paper
• Risk for hospital-acquired pneumonia from proton pump inhibitor or sucralfate in intensive care units

  2012cites this paper
• Adjunctive Therapy in Community-Acquired

  2012cites this paper
• The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study

  2012cites this paper
• Essential role of monocyte chemoattractant protein-1 in gram-negative bacterial pneumonia

  2012cites this paper
• Factors associated with the initiation of proton pump inhibitors in corticosteroid users

  2012cites this paper
• Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.

  2012cites this paper
• Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies

  2011cites this paper
• Proton pump inhibitor side effects and drug interactions: Much ado about nothing?

  2011cites this paper
• Microbial evaluation of proton-pump inhibitors and the risk of pneumonia

  2011cites this paper
• Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease

  2011cites this paper
• Was geschieht mit unangemessenen Verordnungen von Protonen- pumpeninhibitoren nach Krankenhaus-Entlassung?

  2011cites this paper
• Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

  2011cites this paper
• Risk of pneumonia in patients taking statins: population-based nested case-control study.

  2011cites this paper
• Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?

  2011cites this paper
• Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials

  2011cites this paper
• Risk of fracture and pneumonia from acid suppressive drugs.

  2011cites this paper
• Pulmonary aspiration syndromes

  2011cites this paper
• Temporal and within practice variability in the health improvement network

  2011cites this paper
• The 12‐month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro‐oesophageal reflux disease

  2011cites this paper
• articlePharmacotherapy and the risk for community-acquired pneumonia

  2010cites this paper
• Mechanisms of neutrophil accumulation in the lungs against bacteria.

  2010cites this paper
• Statin use does not affect the outcome of acute infection: a prospective cohort study.

  2010cites this paper
• Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population‐based case‐control study

  2010cites this paper
• Statins in community acquired pneumonia: Evidence from experimental and clinical studies.

  2010cites this paper
• Pharmacotherapy and the risk for community-acquired pneumonia

  2010influential citation
• Drug safety issues focusing on liver and pancreas toxicity

  2010cites this paper
• Statins for community-acquired pneumonia: current state of the science

  2010influential citation
• Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.

  2010cites this paper
• Advances in the prevention, management, and treatment of community-acquired pneumonia

  2010cites this paper
• Community-acquired pneumonia in the elderly.

  2010cites this paper
• Postoperative pneumonia in elderly patients receiving acid suppressants: a retrospective cohort analysis

  2010cites this paper
• Statin Treatment and Mortality in Bacterial Infections – A Systematic Review and Meta-Analysis

  2010cites this paper